Economic Burden of Juvenile Idiopathic Arthriti...

By Melike Belenli Gümüş

July 17, 2024

Introduction Juvenile Idiopathic Arthritis (JIA) is a chronic condition affecting children and adole...
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
Enhancing Early Diagnosis and Care for Juvenile Idiopathic Arthritis
The Significant Bias in Nutrition Research Due to Food Composition Variability
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Drug Discovery with AI: A Glimpse into the Future of Pharmaceuticals
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Life Sciences Summit Finalists Set to Transform Healthcare
An Update on The Economic Impact of Adult Immunisation
Economics in Clinical Trials: A Guide to Value-Based Decisions
Clinical Trials in Saudi Arabia: An Insight from PDC-CRO